FUSIDATE DE SODIUM ESSENTIAL PHARMA 500 mg, powder and solution for parenteral use for dilution bottle, 10 ml
Active ingredients: Fusidate sodium
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder and solution for parenteral usebottle, 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FUSIDATE DE SODIUM ESSENTIAL PHARMA 500 mg, poudre et solution pour usage parentéral à diluer
- Pharmaceutical form
- poudre et solution pour usage parentéral
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 500 mg - 1 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- ESSENTIAL PHARMA (M) (MALTE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Oct 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67173874CIP75566611CIP133400955666110Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUSIDATE DE SODIUMpoudre | 500 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.